In the last few years, there have been significant advances in migraine management and
prevention. Lasmiditan, ubrogepant, rimegepant and monoclonal antibodies (erenumab …

Calcitonin gene-related peptide (CGRP), a 37 amino-acid neuropeptide found mostly in
peptidergic sensory C-fibers, has been suggested to be implicated in the pathogenesis of …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Background The objective of this study was to describe patterns in monthly migraine days
(MMD) and tablet utilization, and to estimate health-related quality of life (HRQoL) measures …

Background Gastric cancer (GC) is the most prevalent gastrointestinal tumor with an
unfavorable clinical prognosis. GC patients are largely threatened owing to metastasis and …

Abstract Purpose of Review Migraine is one of the top reasons for consulting a pediatric
neurologist. Although the majority of children and adolescents who receive evidence-based …

Introduction Gepants are small molecules targeting the calcitonin gene-related peptide
(CGRP) that have been recently introduced and are under additional clinical development …

Abstract Background and Objective The calcitonin gene-related peptide (CGRP) is a new
therapeutic target in migraine—a common disorder resulting in reduced quality of life. The …

Introduction Calcitonin gene-related peptide (CGRP) is a vasodilatory neuropeptide
involved in the pathophysiology of migraine, a highly disabling neurovascular disorder …

Migraine is a common form of primary headache, affecting up to 1 in every 6 Americans. The
pathophysiology is an intricate interplay of genetic factors and environmental influence and …